Patricia Mcloughlin PhD

Patricia McLoughlin PhD is Director Companion Diagnostic Partnerships, Global Business Development at QIAGEN, where her responsibilities involve establishing and managing relationships with Pharma partners for the development of Companion Diagnostic assays for approval with their drugs.

Dr McLoughlin started her career as a Research Assistant at The State University of New York before moving to Affymax Research Institute in California as a Research Associate. Dr McLoughlin then moved to F Hoffmann - La Roche Pharmaceuticals in Basel in 2002 where she worked her way through roles of increasing responsibility in the core Genomics and biomarker technology department of Roche, until she was head of Genomics in 2008. During this time she was a key contributor to the establishment of profiling technologies and biomarker sampling in clinical trials across all disease areas in which Roche is active. Her last role at Roche was VP Global Head of Operations, in the Translational Research Sciences department. Most recently Dr McLoughlin worked at Leica Biosystems as Director of Strategic Alliances – Pharma Partnerships where she established relationships with Pharma clients requiring Immunohistochemistry-based CDx assays.

Dr McLoughlin holds a BSc (hons) in Microbiology from the National University of Ireland, Galway, and a Ph.D. in Molecular Biology from the University of Zurich.